
Walter E. Webb
Examiner (ID: 5438, Phone: (571)270-3287 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612, 4133 |
| Total Applications | 1277 |
| Issued Applications | 576 |
| Pending Applications | 113 |
| Abandoned Applications | 605 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6918746
[patent_doc_number] => 20050096307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions'
[patent_app_type] => utility
[patent_app_number] => 10/980380
[patent_app_country] => US
[patent_app_date] => 2004-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19935
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20050096307.pdf
[firstpage_image] =>[orig_patent_app_number] => 10980380
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/980380 | Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions | Nov 2, 2004 | Abandoned |
Array
(
[id] => 6917718
[patent_doc_number] => 20050095279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Transdermal analgesic systems having reduced abuse potential'
[patent_app_type] => utility
[patent_app_number] => 10/975156
[patent_app_country] => US
[patent_app_date] => 2004-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 23822
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20050095279.pdf
[firstpage_image] =>[orig_patent_app_number] => 10975156
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/975156 | Transdermal analgesic systems having reduced abuse potential | Oct 26, 2004 | Abandoned |
Array
(
[id] => 7250590
[patent_doc_number] => 20050074497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases'
[patent_app_type] => utility
[patent_app_number] => 10/971997
[patent_app_country] => US
[patent_app_date] => 2004-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3927
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20050074497.pdf
[firstpage_image] =>[orig_patent_app_number] => 10971997
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/971997 | Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases | Oct 21, 2004 | Abandoned |
Array
(
[id] => 5080246
[patent_doc_number] => 20070123470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-31
[patent_title] => 'Enhancement of growth hormone levels with a dipeptidyl peptidase IV inhibitor and a growth hormone secretagogue'
[patent_app_type] => utility
[patent_app_number] => 10/575047
[patent_app_country] => US
[patent_app_date] => 2004-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6906
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20070123470.pdf
[firstpage_image] =>[orig_patent_app_number] => 10575047
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/575047 | Enhancement of growth hormone levels with a dipeptidyl peptidase IV inhibitor and a growth hormone secretagogue | Oct 19, 2004 | Abandoned |
Array
(
[id] => 7159781
[patent_doc_number] => 20050084521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Antimicrobial adhesive sheet and antimicrobial method using the same'
[patent_app_type] => utility
[patent_app_number] => 10/962622
[patent_app_country] => US
[patent_app_date] => 2004-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6021
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20050084521.pdf
[firstpage_image] =>[orig_patent_app_number] => 10962622
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/962622 | Antimicrobial adhesive sheet and antimicrobial method using the same | Oct 12, 2004 | Abandoned |
Array
(
[id] => 7005897
[patent_doc_number] => 20050171210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Compositions and methods for treatment of cardiovascular disorders and diseases'
[patent_app_type] => utility
[patent_app_number] => 10/952367
[patent_app_country] => US
[patent_app_date] => 2004-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4891
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20050171210.pdf
[firstpage_image] =>[orig_patent_app_number] => 10952367
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/952367 | Compositions and methods for treatment of cardiovascular disorders and diseases | Sep 28, 2004 | Abandoned |
Array
(
[id] => 6971363
[patent_doc_number] => 20050037073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 10/947222
[patent_app_country] => US
[patent_app_date] => 2004-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6452
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20050037073.pdf
[firstpage_image] =>[orig_patent_app_number] => 10947222
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/947222 | Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof | Sep 22, 2004 | Abandoned |
Array
(
[id] => 6930815
[patent_doc_number] => 20050281850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Cosmetic/dermatological inverse emulsions containing calcitriol and clobetasol 17-propionate'
[patent_app_type] => utility
[patent_app_number] => 10/944887
[patent_app_country] => US
[patent_app_date] => 2004-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7505
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20050281850.pdf
[firstpage_image] =>[orig_patent_app_number] => 10944887
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/944887 | Cosmetic/dermatological inverse emulsions containing calcitriol and clobetasol 17-propionate | Sep 20, 2004 | Abandoned |
Array
(
[id] => 6982785
[patent_doc_number] => 20050152855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Materials for enhanced delivery of hydrophilic active agents in personal care formulations'
[patent_app_type] => utility
[patent_app_number] => 10/945273
[patent_app_country] => US
[patent_app_date] => 2004-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13261
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20050152855.pdf
[firstpage_image] =>[orig_patent_app_number] => 10945273
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/945273 | Materials for enhanced delivery of hydrophilic active agents in personal care formulations | Sep 19, 2004 | Abandoned |
Array
(
[id] => 7038817
[patent_doc_number] => 20050158251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Agents for bleaching teeth'
[patent_app_type] => utility
[patent_app_number] => 10/935813
[patent_app_country] => US
[patent_app_date] => 2004-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5386
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158251.pdf
[firstpage_image] =>[orig_patent_app_number] => 10935813
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/935813 | Agents for bleaching teeth | Sep 7, 2004 | Abandoned |
Array
(
[id] => 5851868
[patent_doc_number] => 20060235059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Cancer treatment with epothilones'
[patent_app_type] => utility
[patent_app_number] => 10/570850
[patent_app_country] => US
[patent_app_date] => 2004-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13192
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20060235059.pdf
[firstpage_image] =>[orig_patent_app_number] => 10570850
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/570850 | Cancer treatment with epothilones | Aug 31, 2004 | Abandoned |
Array
(
[id] => 5603045
[patent_doc_number] => 20060293390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Diflunisal for the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 10/569630
[patent_app_country] => US
[patent_app_date] => 2004-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5722
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20060293390.pdf
[firstpage_image] =>[orig_patent_app_number] => 10569630
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/569630 | Diflunisal for the treatment of cancer | Aug 17, 2004 | Abandoned |
Array
(
[id] => 5786847
[patent_doc_number] => 20060205795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Cancer treatment with epothilones'
[patent_app_type] => utility
[patent_app_number] => 10/561757
[patent_app_country] => US
[patent_app_date] => 2004-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14040
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205795.pdf
[firstpage_image] =>[orig_patent_app_number] => 10561757
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/561757 | Cancer treatment with epothilones | Jun 24, 2004 | Abandoned |
Array
(
[id] => 4995078
[patent_doc_number] => 20070010423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => 'Compositions comprising balaglitazone and further antidiabetic compounds'
[patent_app_type] => utility
[patent_app_number] => 10/561639
[patent_app_country] => US
[patent_app_date] => 2004-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5042
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20070010423.pdf
[firstpage_image] =>[orig_patent_app_number] => 10561639
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/561639 | Compositions comprising balaglitazone and further antidiabetic compounds | Jun 23, 2004 | Abandoned |
Array
(
[id] => 5590892
[patent_doc_number] => 20060040344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Microbial process for the preparation of 7-keto dehydroepiandrosterone and related analogs'
[patent_app_type] => utility
[patent_app_number] => 10/540370
[patent_app_country] => US
[patent_app_date] => 2004-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3958
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20060040344.pdf
[firstpage_image] =>[orig_patent_app_number] => 10540370
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/540370 | Microbial process for the preparation of 7-keto dehydroepiandrosterone and related analogs | Jun 20, 2004 | Abandoned |
Array
(
[id] => 7276386
[patent_doc_number] => 20040235837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Method for treating fibrotic diseases or other indications IE'
[patent_app_type] => new
[patent_app_number] => 10/873056
[patent_app_country] => US
[patent_app_date] => 2004-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20704
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235837.pdf
[firstpage_image] =>[orig_patent_app_number] => 10873056
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/873056 | Method for treating fibrotic diseases or other indications IE | Jun 20, 2004 | Abandoned |
Array
(
[id] => 7055589
[patent_doc_number] => 20050276762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-15
[patent_title] => 'Topical compositions containing 5\'-adenosine-diphosphate ribose'
[patent_app_type] => utility
[patent_app_number] => 10/868557
[patent_app_country] => US
[patent_app_date] => 2004-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12482
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20050276762.pdf
[firstpage_image] =>[orig_patent_app_number] => 10868557
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/868557 | Topical compositions containing 5'-adenosine-diphosphate ribose | Jun 14, 2004 | Abandoned |
Array
(
[id] => 5608391
[patent_doc_number] => 20060269907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Decontamination of biological fluids using diphenylpyrilium compounds'
[patent_app_type] => utility
[patent_app_number] => 10/558560
[patent_app_country] => US
[patent_app_date] => 2004-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11798
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20060269907.pdf
[firstpage_image] =>[orig_patent_app_number] => 10558560
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/558560 | Decontamination of biological fluids using diphenylpyrilium compounds | Jun 3, 2004 | Abandoned |
Array
(
[id] => 5662111
[patent_doc_number] => 20060252707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Pharmaceutical composition for the treatment and/or the prevention of atherosclerosis from infectious origin'
[patent_app_type] => utility
[patent_app_number] => 10/558503
[patent_app_country] => US
[patent_app_date] => 2004-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12150
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252707.pdf
[firstpage_image] =>[orig_patent_app_number] => 10558503
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/558503 | Pharmaceutical composition for the treatment and/or the prevention of atherosclerosis from infectious origin | May 27, 2004 | Abandoned |
Array
(
[id] => 5924423
[patent_doc_number] => 20060241122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Combination therapy for the treatment of neoplasms'
[patent_app_type] => utility
[patent_app_number] => 10/559039
[patent_app_country] => US
[patent_app_date] => 2004-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11018
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20060241122.pdf
[firstpage_image] =>[orig_patent_app_number] => 10559039
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/559039 | Combination therapy for the treatment of neoplasms | May 26, 2004 | Abandoned |